Used as a potent inhibitor in kinase-targeted therapies, particularly in oncology research. Shows promising activity against tyrosine kinase receptors involved in tumor growth and angiogenesis. Commonly employed in the development of anticancer agents, especially for solid tumors. Its structure enables selective binding to ATP sites in kinases, enhancing specificity and reducing off-target effects. Also utilized in structure-activity relationship (SAR) studies to optimize potency and pharmacokinetic properties in drug discovery pipelines.